Results 181 to 190 of about 73,750 (253)

Prion and Prion Diseases

, 2020
This review article provides the main information regarding a specific category of infectious diseases of animals and humans, the so-called transmissible spongiform encephalopathies, or prion infections. In a brief introduction explains the need for lighting issues in relation to environmental, veterinary public health importance in traffic and the ...
openaire   +1 more source

Downregulation of STAT3 transcription factor reverses synaptotoxic phenotype of reactive astrocytes associated with prion diseases. [PDF]

Acta Neuropathol Commun
Kushwaha R, Molesworth K, Makarava N, Baskakov IV.   +3 more
europepmc   +1 more source

Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms. [PDF]

Euro Surveill, 2023
Denouel A, Brandel JP, Peckeu-Abboud L, Seilhean D, Bouaziz-Amar E, Quadrio I, Oudart JB, Lehmann S, Bellecave P, Laplanche JL, Haik S.   +10 more
europepmc   +1 more source

Post-translational modifications in prion diseases. [PDF]

Front Mol Neurosci
Bizingre C, Bianchi C, Baudry A, Alleaume-Butaux A, Schneider B, Pietri M.   +5 more
europepmc   +1 more source

Abnormal Expression of Proteolytic Stress-Related Proteins and Protective Effect of Fibrinolytic Enzymes in Prion Diseases. [PDF]

Transbound Emerg Dis
Kim YC, Won SY, Jeong BH.
europepmc   +1 more source

Reactive microglia partially envelop viable neurons in prion diseases. [PDF]

J Clin Invest
Makarava N, Safadi T, Bocharova O, Mychko O, Pandit NP, Molesworth K, Baiardi S, Zhang L, Parchi P, Baskakov IV.   +9 more
europepmc   +1 more source

Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle. [PDF]

PLoS Pathog
Caredio D, Koderman M, Frontzek KJ, Sorce S, Nuvolone M, Bremer J, Mariutti G, Schwarz P, Madrigal L, Mitrovic M, Sellitto S, Streichenberger N, Scheckel C, Aguzzi A.   +13 more
europepmc   +1 more source

Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases. [PDF]

Cell Death Dis
Wen P, Sun Z, Yang D, Li J, Li Z, Zhao M, Wang D, Gou F, Wang J, Dai Y, Zhao D, Yang L.   +11 more
europepmc   +1 more source

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease. [PDF]

Alzheimers Res Ther
Xu B, Xiao K, Jia X, Cao R, Liang D, A R, Zhang W, Li C, Gao L, Chen C, Shi Q, Dong X.   +11 more
europepmc   +1 more source

Topological confinement by a membrane anchor suppresses phase separation into protein aggregates: Implications for prion diseases. [PDF]

Proc Natl Acad Sci U S A
Gogte K, Mamashli F, Herrera MG, Kriegler S, Bader V, Kamps J, Grover P, Winter R, Winklhofer KF, Tatzelt J.   +9 more
europepmc   +1 more source